Cognivue’s FDA Clearance Data Published in the World Journal of Psychiatry

We are excited to announce that Cognivue’s peer-reviewed article, “Validity, reliability and psychometric properties of a computerized cognitive assessment” was published in the World Journal of Psychiatry (WJP). Cognivue is an important and innovative psychometric tool for cognitive evaluation. This article describes data that are fundamental indicators of its sophistication in evaluating cognitive impairment and cost-effective applicability in clinical practice.

Click here to download the full article.

Testimonials

Incorporating Cognivue Thrive can expand the diagnostic assessment of the patient’s overall health picture, allowing more comprehensive vision care.

Dr. Michael Pier, OD.

News

Sign-up to schedule a Cognivue demo!

Click Here